Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4–Targeted Antibody–Drug Conjugate Enfortumab Vedotin in Bladder Cancer
Year: 2025
Type: article
Source: Cancer Research
Authors: Jilin Wu, Bisheng Cheng, Yuxuan Song, Jiahui Cheng, Hanlin Gao, Xing Luo, Ming Huang, Fei Wang, Yiqing Du, Caipeng Qin, Tao Xu
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funders: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Beijing Municipal Science and Technology Commission, Peking University People's Hospital, National Science and Technology Major Project, Beijing Municipal Natural Science Foundation, Capital Health Research and Development of Special Fund, Basic and Applied Basic Research Foundation of Guangdong Province
OpenAlex ID: W4415033458
